Expert Outlook: Eli Lilly and Co Through The Eyes Of 25 Analysts
Portfolio Pulse from Benzinga Insights
Over the past three months, 25 analysts have shared their insights on Eli Lilly and Co (NYSE:LLY), with a majority expressing bullish sentiments. The average 12-month price target has increased by 4.14% to $930.96. Key analysts have maintained or raised their ratings and price targets, reflecting positive financial performance and strong market position.
July 24, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Eli Lilly and Co (NYSE:LLY) has received predominantly bullish ratings from analysts over the past three months. The average 12-month price target has increased by 4.14% to $930.96, with several analysts raising their price targets and maintaining positive ratings. The company's strong financial performance, including a 25.98% revenue growth rate and impressive net margins, supports these positive outlooks.
The majority of analysts have expressed bullish sentiments towards Eli Lilly, with several raising their price targets. The company's strong financial performance, including significant revenue growth and high net margins, supports the positive outlook. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100